Article info

Download PDFPDF
Original article
Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy
  1. Correspondence to Dr Willem A Dik, Department of Immunology, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands; w.dik{at}erasmusmc.nl
View Full Text

Citation

van Steensel L, van Hagen PM, Paridaens D, et al
Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy

Publication history

  • Accepted December 26, 2010
  • First published February 10, 2011.
Online issue publication 
April 19, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.